An experimental animal model of fulminant hepatic failure in pigs

被引:6
|
作者
Lee, KU
Zheng, LX
Cho, YB
Kim, KH
Ha, J
Suh, KS
Jung, SE
机构
[1] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 110744, South Korea
[2] Harbin Med Coll, Affiliated Hosp 2, Dept Surg, Harbin, Peoples R China
关键词
models; animal; liver failure; acute; hepatic artery; hepatic encephalopathy;
D O I
10.3346/jkms.2005.20.3.427
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study was to develop an experimental animal model of fulminant hepatic failure to test the efficacy of the bioartificial liver system. The portal vein and the hepatic artery were clamped intermittently and then the hepatic artery was ligated (ligation group, n = 5). Pigs whose hepatic arteries were not ligated after clamping were assigned to the non-ligation group (n = 5). The biochemical changes in blood, histologic alterations of the liver and neurologic examination for pigs were checked up. All animals died within 17 hr in the ligation group. On the other hand, all animals survived more than 7 days in the non-ligation group. In the ligation group, the levels of ammonia, lactic acid and creatinine showed a progressively increasing pattern. Prothrombin time was also prolonged gradually. Cytoplasmic condensation and nuclear pyknosis of hepatocytes were detected histologically at autopsy. Neurologic findings such as decreased pain sensation, tachypnea and no light reflex of pupils were observed. The findings shown in the ligation group are similar to the clinical features of fulminant hepatic failure in human and this animal model is reproducible. Therefore, this can be a suitable animal model to evaluate the efficacy of the bioartificial liver system for treating fulminant hepatic failure.
引用
收藏
页码:427 / 432
页数:6
相关论文
共 50 条
  • [1] Hepatic stimulator substance activity in animal model of fulminant hepatic failure and encephalopathy
    Margeli, AP
    Manolis, E
    Skaltsas, SN
    Tsarpalis, KS
    Mykoniatis, MG
    Theocharis, SE
    DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (10) : 2170 - 2178
  • [2] Hepatic Stimulator Substance Activity in Animal Model of Fulminant Hepatic Failure and Encephalopathy
    Alexandra P. Margeli
    Evangelos Manolis
    Spyridon N. Skaltsas
    Kyriakos S. Tsarpalis
    Michael G. Mykoniatis
    Stamatios E. Theocharis
    Digestive Diseases and Sciences, 2002, 47 : 2170 - 2178
  • [3] ANIMAL-MODELS OF FULMINANT HEPATIC-FAILURE
    TERBLANCHE, J
    HICKMAN, R
    DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (06) : 770 - 774
  • [4] Hepatic stimulator substance administration ameliorates liver regeneration in an animal model of fulminant hepatic failure and encephalopathy
    Margeli, AP
    Papadimitriou, L
    Ninos, S
    Manolis, E
    Mykoniatis, MG
    Theocharis, SE
    LIVER INTERNATIONAL, 2003, 23 (03): : 171 - 178
  • [5] A surgical model of fulminant hepatic failure in rabbits
    Hung, Kuo-Chen
    Yong, Chee-Chien
    Chen, Yaw-Sen
    Eng, Hock-Liew
    Kuo, Fang-Ying
    Lin, Chi-Chang
    Young, Tai-Horng
    Kobayashi, Eiji
    Chen, Chao-Long
    Wang, Chih-Chi
    LIVER INTERNATIONAL, 2007, 27 (10) : 1333 - 1341
  • [6] Fulminant hepatic failure
    Kurtovic J.
    Riordan S.M.
    Williams R.
    Current Treatment Options in Gastroenterology, 2005, 8 (6) : 503 - 518
  • [7] Fulminant hepatic failure
    Albert J. Chang
    Vivek Dixit
    Sammy Saab
    Current Treatment Options in Gastroenterology, 2003, 6 (6) : 473 - 479
  • [8] Fulminant hepatic failure
    Poniachik, J
    Quera, R
    Liu, A
    REVISTA MEDICA DE CHILE, 2002, 130 (06) : 691 - 698
  • [9] A modified surgical model of fulminant hepatic failure in the rat
    Detry, Olivier
    Gaspar, Yves
    Cheramy-Bien, Jean-Paul
    Drion, Pierre
    Meurisse, Michel
    Defraigne, Jean-Olivier
    JOURNAL OF SURGICAL RESEARCH, 2013, 181 (01) : 85 - 90
  • [10] Management of fulminant hepatic failure
    Detry, O
    Honoré, P
    Meurisse, M
    Jacquet, N
    ACTA CHIRURGICA BELGICA, 1998, 98 (06) : 235 - 240